Organisation paid for research Program year 2024 Source: CMS Open Payments

Max Benzaquen

Neither a doctor nor a teaching hospital

Research payments

$164,247

30 payments

Through program year 2024, Max Benzaquen is reported as receiving $164,247 in research payments, across 30 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2024	Research	$6,015	4
2022	Research	$21,885	2
2021	Research	$12,367	7
2020	Research	$123,980	17

Breakdown

Who paid Research payments · program years 2020–2024

SK Life Science, Inc. $158,232 26 payments
Takeda Pharmaceuticals U.S.A., Inc. $6,015 4 payments

Studies the money was for Research payments · program years 2020–2024

59566 $54,059 7 payments
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures $38,383 3 payments
059566 $35,992 4 payments
1-Fa7759 $14,588 6 payments
1-Q3ras $9,027 2 payments
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy $6,015 4 payments
45569 $3,779 1 payment
045569 $2,404 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.